drugset / Trial / NCT02476058
A Safety, Efficacy and Biomarker Study of JNJ-42847922 in Participants With Major Depressive Disorder
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to evaluate the safety and tolerability of JNJ-42847922 in participants with Major Depressive Disorder (MDD).
Timeline
- Start
- 2015-06-11
- Primary completion
- 2016-01-04
- Completion
- 2016-01-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Diphenhydramine | Unknown | 25 mg | Oral |
| Subject | Seltorexant | Small molecule | 20 mg | Oral |